公开(公告)号：US20180116996A1

公开(公告)日：2018-05-03

申请号：US15795971

申请日：2017-10-27

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Kyungsu KANG ,  Yongsoo CHOI ,  Cheol-Ho PAN ,  Sang Min KIM ,  Kwang-Hyun CHA ,  Jin-Chul KIM

IPC: A61K31/336 ,  A61K36/03 ,  A23L33/105

Abstract: Provided is a pharmaceutical composition, a health food composition, or a quasi drug composition for preventing, treating, or improving a disease caused by overproduction of dihydrotestosterone, including fucoxanthin or a Phaeodactylum tricornutum extract as an active ingredient.

公开(公告)号：US20250099390A1

公开(公告)日：2025-03-27

申请号：US18730898

申请日：2023-01-18

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Ki Young CHOI ,  Kwang-Hyun CHA ,  Hwa Seung HAN ,  Jin Soo PARK ,  Dae-geun SONG ,  Myung Suk KIM ,  Hak Cheol KWON

IPC: A61K9/50 ,  A61K35/74 ,  A61K35/745 ,  A61P37/06

Abstract: Provided is a method for preventing, ameliorating, or treating inflammatory diseases by administering a composition containing extracellular vesicles (EVs) derived from Roseburia spp. strains and/or Bifidobacterium spp. strains, wherein the EVs exhibits effectiveness in improving inflammatory bowel disease (IBD), and additionally, all EVs derived from congeneric strains corresponding to Roseburia spp. strains or Bifidobacterium spp. strains. have been confirmed to exhibit strong anti-inflammatory effect, and the strains and EVs derived therefrom can be provided as a composition for preventing, ameliorating, or treating a variety of inflammatory diseases.

公开(公告)号：US20200009172A1

公开(公告)日：2020-01-09

申请号：US16212116

申请日：2018-12-06

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY ,  REPUBLIC OF KOREA(MANAGEMENT : RURAL DEVELOPMENT ADMINISTRATION)

Inventor： Yongsoo CHOI ,  Jin-Chul KIM ,  Su-Nam KIM ,  Kyungsu KANG ,  Seung-Hoon YANG ,  Keunwan PARK ,  Hee Ju LEE ,  Dae-geun SONG ,  Kwang-Hyun CHA ,  Joo Yeong JEON ,  Chang Geon KIM ,  Jung Kyung MOON ,  Man Soo CHOI ,  Soo Kwon PARK ,  Nam Hee JEONG

IPC: A61K31/7048 ,  A61K31/352 ,  A61K36/48 ,  A61P17/00 ,  A61P29/00 ,  A61K9/00 ,  A23L33/105

Abstract: Provided are a composition for preventing or improving inflammation, the composition including an extract of a seed of soybean Glycine max (L.) Merrill cultivar SCEL-1, and a method of preventing occurrence of inflammation in a subject or improving inflammation in a subject, the method including injecting the composition to a subject.

公开(公告)号：US20170340690A1

公开(公告)日：2017-11-30

申请号：US15596404

申请日：2017-05-16

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Cheol-Ho PAN ,  Kyungsu KANG ,  Kwang-Hyun CHA ,  Eun Ha LEE ,  Hee Ju LEE ,  Song Yi KOO ,  Yongsoo CHOI

IPC: A61K36/344 ,  A23L33/135 ,  C12N1/20 ,  A61K35/741 ,  A61K35/00

CPC classification number: A61K36/344 ,  A23L33/135 ,  A23V2002/00 ,  A61K35/741 ,  A61K2035/115 ,  C12N1/20

Abstract: Disclosed is a method for improving intestinal microflora, which includes administering an extract of Codonopsis lanceolata of an amount effective for improving intestinal microflora to a subject in need thereof. The extract can promote the proliferation of beneficial intestinal bacteria and suppress the proliferation of harmful bacteria. Also, the extract can improve intestinal health or intestinal function and improve defecation disorder. In addition, a synergic effect can be obtained when the composition of the present disclosure is used together with probiotics.